FTHI logo

FTHIFirst Trust Exchange-Traded Fund VI - First Trust BuyWrite Income ETF

$23.65
$0.33
(1.38%)
Today
Closed $23.65
$0.00
(0.00%)
After Hours
Updated: 04:10 PM EDT
Vol746,907.00
52W High$24.18
52W Low$22.35
News
all
press releases
News Placeholder
Novo Nordisk To Cut Ozempic, Wegovy Prices By Up To 50%
Ozempic and Wegovy will start at a list price of $675 a month, effective Jan. 1, 2027, according to the company.
Stocktwits
News Placeholder
NVO Stock Continues To Decline Pre-Market After Monday’s Crash Amid CagriSema Setback – But Tuesday Brings Some Hope From China
Developed in partnership with United Laboratories International Holdings, Novo Nordisk said that UBT251 delivered up to 19.7% mean weight loss after 24 weeks in a phase 2 trial in China.
Stocktwits
News Placeholder
Why Is NVO Stock Falling Pre-Market Today?
The company stated that CagriSema demonstrated 23% weight loss in people with obesity, failing to meet its primary endpoint.
Stocktwits
<
...
1
>

Advertisement|Remove ads.